{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T16:51:21Z","timestamp":1771692681541,"version":"3.50.1"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.path.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T01:40:14Z","timestamp":1602207614000},"page":"625-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["New Prognostic Indicators in Pediatric Adrenal Tumors"],"prefix":"10.1016","volume":"13","author":[{"given":"Jason A.","family":"Jarzembowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib1","doi-asserted-by":"crossref","first-page":"e945","DOI":"10.1542\/peds.2013-3926","article-title":"Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009","volume":"134","author":"Siegel","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib2","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"27","key":"10.1016\/j.path.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1542\/pir.2017-0087","article-title":"Clinical presentation, evaluation, and management of neuroblastoma","volume":"39","author":"Sharma","year":"2018","journal-title":"Pediatr Rev"},{"issue":"9","key":"10.1016\/j.path.2020.08.002_bib5","first-page":"119","article-title":"Genetic predisposition to neuroblastoma","volume":"5","author":"Barr","year":"2018","journal-title":"Children (Basel)"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The international neuroblastoma pathology classification (the Shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.path.2020.08.002_bib7","unstructured":"Jarzembowski JA, Rudzinski E, Shimada H. College of American Pathologists: protocol for the examination of specimens from patients with neuroblastoma. 2014."},{"issue":"5","key":"10.1016\/j.path.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAI.0000000000000068","article-title":"Phenotype and immunophenotype of the most common pediatric tumors","volume":"23","author":"Picarsic","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","article-title":"The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report","volume":"27","author":"Monclair","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ejca.2010.10.022","article-title":"Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project","volume":"47","author":"Moroz","year":"2011","journal-title":"Eur J Cancer"},{"issue":"27","key":"10.1016\/j.path.2020.08.002_bib11","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1200\/JCO.2005.05.571","article-title":"Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group","volume":"23","author":"London","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.path.2020.08.002_bib12","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1200\/JCO.2005.05.183","article-title":"Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study","volume":"23","author":"Schmidt","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.path.2020.08.002_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrclinonc.2014.168","article-title":"Mechanisms of neuroblastoma regression","volume":"11","author":"Brodeur","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00441-017-2761-2","article-title":"Spontaneous regression of neuroblastoma","volume":"372","author":"Brodeur","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib15","first-page":"1089","article-title":"In situ neuroblastomas: a contribution to the natural history of neural crest tumors","volume":"43","author":"Beckwith","year":"1963","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00043426-199211000-00007","article-title":"Past and future of neuroblastoma screening in Japan","volume":"14","author":"Sawada","year":"1992","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.path.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00140","article-title":"Statistical framework in support of a revised Children's Oncology Group neuroblastoma risk classification system","volume":"2","author":"Naranjo","year":"2018","journal-title":"JCO Clin Cancer Inform"},{"issue":"33","key":"10.1016\/j.path.2020.08.002_bib18","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1200\/JCO.2011.35.9570","article-title":"Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age","volume":"29","author":"Taggart","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.path.2020.08.002_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cncr.30380","article-title":"Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group","volume":"123","author":"Burchill","year":"2017","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.path.2020.08.002_bib20","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjc.6605029","article-title":"Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force","volume":"100","author":"Beiske","year":"2009","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.path.2020.08.002_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2350\/15-07-1676-OA.1","article-title":"Improving detection of metastatic neuroblastoma in bone marrow core biopsies: a proposed immunohistochemical approach","volume":"19","author":"Parsons","year":"2016","journal-title":"Pediatr Dev Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1093526616686253","article-title":"An evidence-based recommendation for a standardized approach to detecting metastatic neuroblastoma in staging bone marrow biopsies","volume":"20","author":"Parsons","year":"2017","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.5858\/arpa.2014-0255-OA","article-title":"Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow","volume":"139","author":"Hata","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0609.1994.tb01868.x","article-title":"Immunocytochemical detection of bone marrow-invasive neuroblastoma cells","volume":"53","author":"Nagai","year":"1994","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.path.2020.08.002_bib25","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/cncr.11773","article-title":"Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular","volume":"98","author":"Peuchmaur","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jpedsurg.2012.03.040","article-title":"Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children","volume":"47","author":"Hassan","year":"2012","journal-title":"J\u00a0Pediatr Surg"},{"issue":"12","key":"10.1016\/j.path.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.jpedsurg.2017.08.032","article-title":"Diagnostic utility of core needle biopsy versus open wedge biopsy for pediatric intraabdominal solid tumors: results of a prospective clinical study","volume":"52","author":"Deeney","year":"2017","journal-title":"J\u00a0Pediatr Surg"},{"issue":"8","key":"10.1016\/j.path.2020.08.002_bib28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ejca.2005.11.031","article-title":"International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age","volume":"42","author":"Sano","year":"2006","journal-title":"Eur J Cancer"},{"issue":"17","key":"10.1016\/j.path.2020.08.002_bib29","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1200\/JCO.19.03285","article-title":"Age, diagnostic category, tumor grade, and mitosis-karyorrhexis index are independently prognostic in neuroblastoma: an INRG project","volume":"38","author":"Sokol","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1541-7786.MCR-13-0536","article-title":"The N-myc oncogene: maximizing its targets, regulation, and therapeutic potential","volume":"12","author":"Beltran","year":"2014","journal-title":"Mol Cancer Res"},{"issue":"11","key":"10.1016\/j.path.2020.08.002_bib31","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1073\/pnas.82.11.3761","article-title":"Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines","volume":"82","author":"Shiloh","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02940304","article-title":"Pathology of peripheral neuroblastic tumors: significance of prominent nucleoli in undifferentiated\/poorly differentiated neuroblastoma","volume":"13","author":"Torn\u00f3czky","year":"2007","journal-title":"Pathol Oncol Res"},{"issue":"8","key":"10.1016\/j.path.2020.08.002_bib33","doi-asserted-by":"crossref","first-page":"e27819","DOI":"10.1002\/pbc.27819","article-title":"Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: a report from the International Neuroblastoma Risk Group (INRG) project","volume":"66","author":"Campbell","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.path.2020.08.002_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/pbc.24238","article-title":"Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee","volume":"60","author":"Suganuma","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/bjc.2015.188","article-title":"Augmented expression of MYC and\/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study","volume":"113","author":"Wang","year":"2015","journal-title":"Br J Cancer"},{"issue":"7215","key":"10.1016\/j.path.2020.08.002_bib36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of ALK as a major familial neuroblastoma predisposition gene","volume":"455","author":"Moss\u00e9","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.path.2020.08.002_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ccell.2014.09.019","article-title":"ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma","volume":"26","author":"Bresler","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(13)70095-0","article-title":"Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study","volume":"14","author":"Moss\u00e9","year":"2013","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.path.2020.08.002_bib39","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1158\/0008-5472.CAN-19-3068","article-title":"Telomere maintenance mechanisms define clinical outcome in high-risk neuroblastoma","volume":"80","author":"Koneru","year":"2020","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.path.2020.08.002_bib40","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/ng.3438","article-title":"TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors","volume":"47","author":"Valentijn","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.path.2020.08.002_bib41","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jpedsurg.2014.09.029","article-title":"Clinical features of ATRX or DAXX mutated neuroblastoma","volume":"49","author":"Kurihara","year":"2014","journal-title":"J\u00a0Pediatr Surg"},{"issue":"9","key":"10.1016\/j.path.2020.08.002_bib42","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.bjc.6605014","article-title":"International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee","volume":"100","author":"Ambros","year":"2009","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pbc.22106","article-title":"Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG","volume":"53","author":"Okamatsu","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.path.2020.08.002_bib44","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1158\/1078-0432.CCR-08-1815","article-title":"Trk receptor expression and inhibition in neuroblastomas","volume":"15","author":"Brodeur","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng.2493","article-title":"Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma","volume":"45","author":"Sausen","year":"2013","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.path.2020.08.002_bib46","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(09)70154-8","article-title":"Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN\/COG\/GPOH study","volume":"10","author":"Vermeulen","year":"2009","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.path.2020.08.002_bib47","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2009.27.3367","article-title":"Prognostic impact of gene expression-based classification for neuroblastoma","volume":"28","author":"Oberthuer","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-018-2821-2","article-title":"Neuroblastoma: clinical and biological approach to risk stratification and treatment","volume":"372","author":"Tolbert","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2020.08.002_bib50","series-title":"SEER cancer statistics review, 1975-2007","year":"2010"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO;2-Y","article-title":"Risk factors for adrenal cancer: an exploratory study","volume":"65","author":"Hsing","year":"1996","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.path.2020.08.002_bib52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2020.08.002_bib53","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2350\/08-06-0489.1","article-title":"Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors?","volume":"12","author":"Dehner","year":"2009","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.path.2020.08.002_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ajcp\/72.3.390","article-title":"Prognostic factors in adrenal cortical tumors: a mathematical analysis of clinical and morphologic data","volume":"72","author":"Hough","year":"1979","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2020.08.002_bib56","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/1097-0142(19850215)55:4<766::AID-CNCR2820550414>3.0.CO;2-7","article-title":"Morphologic characteristics of benign and malignant adrenocortical tumors","volume":"55","author":"van Slooten","year":"1985","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2020.08.002_bib57","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.path.2020.08.002_bib58","first-page":"2027","article-title":"Childhood adrenocortical tumors","volume":"82","author":"Sandrini","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/his.13255","article-title":"Challenges in surgical pathology of adrenocortical tumours","volume":"72","author":"Erickson","year":"2018","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12022-018-9525-8","article-title":"Immunohistochemical biomarkers of adrenal cortical neoplasms","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.path.2020.08.002_bib61","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3346\/jkms.2017.32.5.764","article-title":"Myxoid and sarcomatoid variants of adrenocortical carcinoma: analysis of rare variants in single tertiary care center","volume":"32","author":"Sung","year":"2017","journal-title":"J\u00a0Korean Med Sci"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpedsurg.2015.10.039","article-title":"Factors associated with survival in pediatric adrenocortical carcinoma: an analysis of the National Cancer Data Base (NCDB)","volume":"51","author":"Gulack","year":"2016","journal-title":"J\u00a0Pediatr Surg"},{"issue":"35","key":"10.1016\/j.path.2020.08.002_bib63","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1200\/JCO.2017.74.2460","article-title":"Identification of clinical and biologic correlates associated with outcome in children with adrenocortical tumors without germline TP53 mutations: a St Jude Adrenocortical Tumor Registry and Children's Oncology Group study","volume":"35","author":"Pinto","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib64","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0022-3468(93)90341-H","article-title":"Adrenocortical carcinoma in children: clinical aspects and prognosis","volume":"28","author":"Sabbaga","year":"1993","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.path.2020.08.002_bib65","series-title":"AJCC cancer staging manual","first-page":"911","article-title":"Adrenal Cortical","year":"2017"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib66","first-page":"2338","article-title":"The impact of tumor stage on prognosis in children with adrenocortical carcinoma","volume":"174","author":"Tucci","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.path.2020.08.002_bib67","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ajcp\/101.5.625","article-title":"Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors","volume":"101","author":"Bugg","year":"1994","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.path.2020.08.002_bib68","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/1097-0142(19860601)57:11<2235::AID-CNCR2820571127>3.0.CO;2-O","article-title":"Comparison of adrenal cortical tumors in children and adults","volume":"57","author":"Cagle","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.path.2020.08.002_bib69","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib70","doi-asserted-by":"crossref","first-page":"563-571","DOI":"10.1007\/s00383-015-3708-x","article-title":"Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children","volume":"31","author":"Chatterjee","year":"2015","journal-title":"Pediatr Surg Int"},{"issue":"11","key":"10.1016\/j.path.2020.08.002_bib71","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jpedsurg.2016.07.014","article-title":"Wieneke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: is there a correlation?","volume":"51","author":"Das","year":"2016","journal-title":"J\u00a0Pediatr Surg"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1677\/ERC-08-0237","article-title":"Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas","volume":"16","author":"Soon","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.path.2020.08.002_bib73","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0b013e31828d387b","article-title":"The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases","volume":"37","author":"Duregon","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2020.08.002_bib74","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","article-title":"Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification","volume":"55","author":"Volante","year":"2009","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.path.2020.08.002_bib75","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3390\/cancers11111730","article-title":"The prognostic role of CD8+ T lymphocytes in childhood adrenocortical carcinomas compared to Ki-67, PD-1, PD-L1, and the weiss score","volume":"11","author":"Parise","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.path.2020.08.002_bib76","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/pbc.25118","article-title":"Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT)","volume":"61","author":"Leite","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2011.04.016","volume":"43","author":"Magro","year":"2012","journal-title":"Hum Pathol"},{"issue":"1\u20132","key":"10.1016\/j.path.2020.08.002_bib78","first-page":"96-102","article-title":"The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families","volume":"245","author":"Achatz","year":"2007","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib79","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a Children's Oncology Group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.path.2020.08.002_bib80","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1210\/jcem.86.10.7957","article-title":"An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors","volume":"86","author":"Latronico","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.path.2020.08.002_bib81","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1158\/0008-5472.CAN-10-2014","article-title":"Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers","volume":"70","author":"Ragazzon","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2011.09.040","article-title":"Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults","volume":"351","author":"Faria","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.path.2020.08.002_bib83","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib84","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2011.09.042","article-title":"Insulin-like growth factor system on adrenocortical tumorigenesis","volume":"351","author":"Ribeiro","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.path.2020.08.002_bib85","first-page":"2048","article-title":"Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression","volume":"85","author":"Wilkin","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib86","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/0008-5472.CAN-06-3767","article-title":"Gene expression profiling of childhood adrenocortical tumors","volume":"67","author":"West","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib87","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1530\/ERC-15-0426","article-title":"IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis","volume":"23","author":"Peixoto Lira","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.path.2020.08.002_bib88","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/ERC-16-0266","article-title":"Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas","volume":"23","author":"Creemers","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.path.2020.08.002_bib89","first-page":"1444","article-title":"Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors","volume":"78","author":"Gicquel","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.path.2020.08.002_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cancergencyto.2008.05.010","article-title":"High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation","volume":"186","author":"Rosati","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"issue":"9","key":"10.1016\/j.path.2020.08.002_bib91","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1210\/jc.2008-0065","article-title":"Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors","volume":"93","author":"Almeida","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.path.2020.08.002_bib92","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","article-title":"Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors","volume":"70","author":"Doghman","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.path.2020.08.002_bib93","first-page":"1116","article-title":"Comparative genomic hybridization analysis of adrenocortical tumors of childhood","volume":"84","author":"Figueiredo","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib94","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6990691","article-title":"Highly consistent genetic alterations in childhood adrenocortical tumours detected by comparative genomic hybridization","volume":"81","author":"James","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.path.2020.08.002_bib95","first-page":"167","article-title":"Steroidogenic factor 1 plays multiple roles in endocrine development and function","volume":"52","author":"Wong","year":"1997","journal-title":"Recent Prog Horm Res"},{"issue":"3","key":"10.1016\/j.path.2020.08.002_bib96","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1210\/jc.2009-2040","article-title":"Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults","volume":"95","author":"Almeida","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.path.2020.08.002_bib97","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.path.2020.08.002_bib98","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejca.2006.01.022","article-title":"SF-1 overexpression in childhood adrenocortical tumours","volume":"42","author":"Pianovski","year":"2006","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.path.2020.08.002_bib99","doi-asserted-by":"crossref","first-page":"E1284","DOI":"10.1210\/jc.2012-1184","article-title":"SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes","volume":"97","author":"Letouz\u00e9","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2020.08.002_bib100","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.2147\/OTT.S108485","article-title":"Network analysis reveals potential markers for pediatric adrenocortical carcinoma","volume":"9","author":"Kulshrestha","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"3","key":"10.1016\/j.path.2020.08.002_bib101","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF02921352","article-title":"Adrenocortical neoplasms in childhood and adolescence: analysis of prognostic factors including DNA content","volume":"3","author":"Zerbini","year":"1992","journal-title":"Endocr Pathol"},{"issue":"8","key":"10.1016\/j.path.2020.08.002_bib102","first-page":"2776","article-title":"Inactivation of the p16 tumor suppressor gene in adrenocortical tumors","volume":"84","author":"Pilon","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"38","key":"10.1016\/j.path.2020.08.002_bib103","doi-asserted-by":"crossref","first-page":"63835","DOI":"10.18632\/oncotarget.19135","article-title":"GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior","volume":"8","author":"Pinheiro","year":"2017","journal-title":"Oncotarget"},{"issue":"51","key":"10.1016\/j.path.2020.08.002_bib104","doi-asserted-by":"crossref","first-page":"84634","DOI":"10.18632\/oncotarget.12382","article-title":"Unraveling the expression of the oncogene YAP1, a Wnt\/beta-catenin target, in adrenocortical tumors\u00a0and its association with poor outcome in pediatric patients","volume":"7","author":"Abduch","year":"2016","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.path.2020.08.002_bib105","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.path.2020.08.002_bib106","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1210\/jc.2013-4098","article-title":"Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumors","volume":"99","author":"Gomes","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"26","key":"10.1016\/j.path.2020.08.002_bib107","doi-asserted-by":"crossref","first-page":"22724","DOI":"10.18632\/oncotarget.4261","article-title":"Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma","volume":"6","author":"de Sousa","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/ERC-13-0098","article-title":"Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma","volume":"20","author":"Caramuta","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.path.2020.08.002_bib109","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PCR.0000000000000027","article-title":"DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions","volume":"19","author":"Schultz","year":"2014","journal-title":"Pathol Case Rev"},{"issue":"4","key":"10.1016\/j.path.2020.08.002_bib110","doi-asserted-by":"crossref","first-page":"E687","DOI":"10.1210\/jc.2011-3000","article-title":"Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations","volume":"97","author":"Almeida","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918120300532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918120300532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:41:33Z","timestamp":1761748893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918120300532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1875918120300532"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2020.08.002","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Prognostic Indicators in Pediatric Adrenal Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}